$214,000–$275,000
USD/year
Reporting into the Core Asset Team (CAT) Lead, the ideal candidate will lead the global commercial strategy and market development for the high-impact Immunology asset. The ideal candidate will own the go-to-market plan, geographic expansion, lifecycle strategy, and commercial business case plans for ex-US markets while staying in-sync and in step with the US Immunology functional leadership.